Pew Comments on FDA Oversight of Dietary Supplement Ingredients

Pew Comments on FDA Oversight of Dietary Supplement Ingredients

The Pew Charitable Trusts submitted comments to the Food and Drug Administration on July 15, 2019, in response to the agency’s request for ideas to facilitate responsible innovation in dietary supplements while protecting public health. Pew proposed steps that FDA could take to better ensure the safety of new dietary ingredients, and recommended that Congress pass legislation to provide the agency with the basic product information it needs to effectively monitor the supplement market and enforce the law.

Pills in hand
Pills in hand
Article

FDA Lacks Ability to Effectively Safeguard Public From Risky Supplements

Quick View
Article

FDA Lacks Ability to Effectively Safeguard Public From Risky Supplements

The Food and Drug Administration cautioned consumers in January to avoid a product called GoLean Detox. The agency’s laboratory analysis showed that the product contained ingredients from two potentially dangerous drugs, even though it was advertised as an all-natural herbal supplement to help with weight loss.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up